HUMAN TNF-ALPHA
Description Source Background- Product Name
- HUMAN TNF-ALPHA
- CAS No.
- 94948-59-1
- Chemical Name
- HUMAN TNF-ALPHA
- Synonyms
- hTNF-α;CACHECTIN;HUMAN DIF;TNF ALPHA;Tasonermin;HTNF-ALPHA;TNF, HUMAN;HUMAN TNF-A;RHTNF-ALPHA;HUMAN TNFSF2
- CBNumber
- CB4704832
- Molecular Formula
- NULL
- Formula Weight
- 0
- MOL File
- Mol file
HUMAN TNF-ALPHA Property
- storage temp.
- -20°C
- form
- powder
- color
- colorless
- biological source
- human
- Water Solubility
- distilled water: 0.1—1mg/mL
- Specific Activity
- ≥2 * 107U/mg
Safety
- WGK Germany
- 3
- RTECS
- MT6435000
Hazard and Precautionary Statements (GHS)
- Symbol(GHS)
-
- Signal word
- Warning
- Hazard statements
-
H361Suspected of damaging fertility or the unborn child
- Precautionary statements
-
P201Obtain special instructions before use.
P202Do not handle until all safety precautions have been read and understood.
P281Use personal protective equipment as required.
P308+P313IF exposed or concerned: Get medical advice/attention.
P405Store locked up.
P501Dispose of contents/container to..…
N-Bromosuccinimide Price
- Product number
- T6674
- Product name
- Tumor Necrosis Factor-α human
- Purity
- TNF-α, recombinant, expressed in E. coli, powder, suitable for cell culture
- Packaging
- 10μg
- Price
- $259
- Updated
- 2025/07/31
- Product number
- T6674
- Product name
- Tumor Necrosis Factor-α human
- Purity
- TNF-α, recombinant, expressed in E. coli, powder, suitable for cell culture
- Packaging
- 5x10μg
- Price
- $1720
- Updated
- 2025/07/31
- Product number
- H8916
- Product name
- Tumor Necrosis Factor-α human
- Purity
- TNF-α, recombinant, expressed in HEK 293 cells, suitable for cell culture
- Packaging
- 10μg
- Price
- $338
- Updated
- 2025/07/31
- Product number
- 654205-M
- Product name
- TNF-α, Human, Recombinant, <i>E. coli</i>
- Packaging
- 10 μg
- Price
- $583
- Updated
- 2025/07/31
- Product number
- T9160-32A
- Product name
- Tumor Necrosis Factor alpha
- Packaging
- 100ug
- Price
- $212
- Updated
- 2021/12/16
HUMAN TNF-ALPHA Chemical Properties,Usage,Production
Description
Tasonermin was launched in Germany for the treatment of soft tissue sarcoma of the limbs. Recent literature is scarce for this compound. It is the first tumor necrosis factor (TNF) launched for cancer treatment to date and works through destruction of tumor blood vessels. This recombinant protein is expressed in E. coil and purified. Tasonermin is too toxic for systemic use and consequently is being used in isolated limb perfusion (ILP) for sarcoma and malignant melanoma. The product has shown notable efficacy when used in combination with melphalan to prevent amputation. In four European clinical trials involving 260 patients destined for amputation or mutilating surgery, Beromun enabled durable limb salvage in 80% of the patients. Due to the complexity of ILP, the application of tasonermin is restricted to clinical centers with sufficient experience and facilities including radionucleide-based continuous monitoring of leakage from the isolated circuit during ILP and postoperative intensive care surveillance.
Originator
Genentech (US)
Uses
Tumor Necrosis Factor-a human has been used:
- as a permeability inducing agent for endothelial cell monolayer permeability assay
- as a reactive oxygen species inducer in primary rat cardiac microvascular endothelial cells (RCMVECs)
- in the activation of nuclear factor kappa B (NF-κB) in human embryonic kidney cells (HEK293), neuroblastoma SH-SY5Y cells and HeLa cells
- in the stimulation of the human keratinocyte cell line(HaCaT) and human coronary artery endothelial cells (HCAECs)
Uses
TNF-α include stimulating growth of human fibroblasts and other cell lines activating polymorphonuclear neutrophils and osteoclasts and inducing interleukin-1, prostaglandin E2, and collagenase production.
brand name
Beromun
General Description
The TNFα (tumor necrosis factor α) gene is mapped to human chromosome 6p21.33. TNFα is a member of TNF superfamily. TNF-α has a palmitoyl group in the cysteine residue and is phosphorylated in the transmembrane region serine residue.
Biochem/physiol Actions
Tumor Necrosis Factor-α (TNF-α) is a potent pro-inflammatory cytokine that plays a role in the rheumatoid arthritis pathology, psoriatic arthritis (PsA) and psoriasis. It stimulates interleukins IL-1 and IL-6. Polymorphism in the TNF-α gene is associated with destructive arthropathy in PsA. The post-translational modifications in TNF-a is crucial for its functionality.
Description
Tumor Necrosis Factor-a Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 158 amino acids (157 a.a. of the mature human TNF-alpha and an N-terminal methionine) and having a molecular mass of 17.5kDa.
The TNF-alpha is purified by standard chromatographic techniques.
Source
Escherichia Coli
Background
Tumor necrosis factor is a cytokine involved in systemic inflammation and is a member of a group of cytokines that all stimulate the acute phase reaction. TNF is mainly secreted by macrophages.
TNF causes apoptotic cell death, cellular proliferation, differentiation, inflammation, tumorigenesis and viral replication, TNF is also involved in lipid metabolism, and coagulation. TNF's primary role is in the regulation of immune cells.
Dysregulation and, in particular, overproduction of TNF have been implicated in a variety of human diseases- autoimmune diseases, INS resistance, and cancer.
HUMAN TNF-ALPHA Preparation Products And Raw materials
Raw materials
Preparation Products
HUMAN TNF-ALPHA Suppliers
- Tel
- 1-631-485-4226; 16314854226
- info@bocsci.com
- Country
- United States
- ProdList
- 12952
- Advantage
- 65
- Tel
- --
- Fax
- --
- Country
- United States
- ProdList
- 6773
- Advantage
- 87